Patient controlled intravenous analgesia
Conditions
Interventions
group of sufentanil:No
group of oxycodone hydrochloride :No
Sponsors
Xuan Wu hospital of CCMU
Eligibility
Sex/Gender
All
Age
60 Years to No maximum
Inclusion criteria
Inclusion criteria: 1. Aged >= 60 years; 2. Inpatients; 3. ASA I-III; 4. Patients undergoing surgery (orthopedics, thoracic surgery, general surgery); 5. With PCIA, the analgesic drugs are oxycodone hydrochloride injection and sufentanil respectively, and the antiemetic drugs are ondansetron.
Exclusion criteria
Exclusion criteria: 1.Severe respiratory complications before surgery (respiratory failure, blood oxygen saturation less than 90%); 2.Circulatory system diseases (preoperative heart failure, myocardial infarction within 3 months, history of angina pectoris within 1 month); 3.Patients with mental illness; 4.Severely malnourished or morbidly obese patients; 5.Patients with major postoperative complications (i.e. myocardial infarction, cerebrovascular accident, pulmonary embolism, hemorrhage events requiring reoperation) .
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| VAS scores at 24 h postoperatively; | — |
Secondary
| Measure | Time frame |
|---|---|
| The number of self-administered doses of the patient-controlled analgesia;Oxycodone or sufentanil dosage within 24 hours after surgery;The time of first flatus;The incidence of postoperative nausea and vomiting;The incidence of respiratory complications;The incidence of cardiovascular system complications; | — |
Countries
China
Contacts
Public ContactWang Tianlong
Xuanwu Hospital of CCMU
Outcome results
None listed